Symbol | Exchange | Currency |
|---|
Investing.com – U.S. stocks were mixed after the close on Friday, as gains in the Oil & Gas, Consumer Services and Financials sectors led shares higher while losses in the...
Investing.com – U.S. stocks were lower after the close on Wednesday, as losses in the Oil & Gas, Basic Materials and Technology sectors led shares lower. At the close in NYSE, the...
Investing.com – U.S. stocks were mixed after the close on Monday, as gains in the Basic Materials, Telecoms and Oil & Gas sectors led shares higher while losses in the Technology,...
Kintara Therapeutics, Inc. is a clinical-stage, biopharmaceutical company focused on the development and commercialization of new cancer therapies. The Company is developing two late-stage, Phase III-ready therapeutics. The Company's two lead product candidates are VAL-083 and REM-001. VAL- 083 is a validated, Deoxyribonucleic acid (DNA)-targeting agent, for the treatment of drug-resistant solid tumors such as glioblastoma multiforme (GBM) and potentially other solid tumors, including ovarian cancer, non-small cell lung cancer (NSCLC) and diffuse intrinsic pontine glioma (DIPG). REM-001 is a late-stage photodynamic therapy (PDT) for the treatment of cutaneous metastatic breast cancer (CMBC). The Company is carrying out various clinical trials on brain tumor and solid tumor.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Buy | Buy | Sell | Strong Sell | Strong Sell |
| Technical Indicators | Strong Buy | Strong Buy | Sell | Strong Sell | Strong Sell |
| Summary | Strong Buy | Strong Buy | Sell | Strong Sell | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 367.99 | 369.94 | 362.75 | +3.30 | +0.90% | 1.96M | NYSE | |||
| 48.58 | 49.52 | 48.38 | -0.69 | -1.40% | 18.48M | NYSE | |||
| 7.66 | 7.72 | 7.63 | +0.03 | +0.39% | 4.19M | NASDAQ | |||
| 121.71 | 122.21 | 118.41 | +2.52 | +2.11% | 90.72K | NYSE | |||
| 8.78 | 9.15 | 8.46 | +0.13 | +1.50% | 82.33K | NASDAQ | |||
| 0.8075 | 0.8199 | 0.7801 | -0.0087 | -1.07% | 101.34K | NASDAQ | |||
| 15.61 | 15.75 | 15.61 | +0.04 | +0.26% | 75.09K | NYSE | |||
| 245.17 | 246.48 | 239.28 | +4.02 | +1.67% | 5.27M | NASDAQ | |||
| 1.21 | 1.33 | 1.15 | -0.060 | -4.72% | 162.67K | NASDAQ | |||
| 304.27 | 304.57 | 301.55 | +0.01 | 0.00% | 2.77M | NYSE | |||
| 31.98 | 32.95 | 31.78 | -0.47 | -1.45% | 3.18M | NYSE | |||
| 0.0065 | 0.0076 | 0.0065 | -0.0011 | -14.53% | 117.33K | OTC Markets | |||
| 17.37 | 17.49 | 16.01 | +1.11 | +6.83% | 1.65M | NYSE | |||
| 28.20 | 28.20 | 28.20 | 0.0 | 0.00% | 125.00 | OTC Markets | |||
| 0.235 | 0.26 | 0.23 | -0.003 | -1.22% | 55.80K | NASDAQ |